Back

Arrhythmia burden in patients with congenital heart disease

2 September 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: New tools for prognostication in congenital heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Filip Eckerstrom

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

9 More presentations in this session

Presentation thumbnail
The relation between atrial arrhythmias and heart failure in adult patients with congenital heart disease
Doctor C. Lauwers (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
High prevalence of coronary artery calcium and aortic calcification in adults with repaired coarctation of the aorta and interrupted aortic arch
Doctor M. Lee (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Blood biomarkers to detect functional impairment in adult patients with repaired Tetralogy of Fallot
Doctor S. Alborikan (London, GB)
Abstract Slides Video
Presentation thumbnail
The ventricular septal defect in tetralogy of Fallot: A multi-centre morphological and statistical shape analysis study
Miss V. Sabarigirivasan (London, GB)
Abstract Slides Video
Presentation thumbnail
Interaction between right atrial function reserve and liver stiffness after complete repair of tetralogy of fallot: a pilot study
Mr W. Chik (Hong Kong, HK)
Abstract Slides Video

Access the full session

Session thumbnail
New tools for prognostication in congenital heart disease

The Event

Event poster

ESC Congress 2024

2 September 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Timing and technique matter: closure of secundum atrial septal defect and risk of incident and recurrent arrhythmia
thumbnail
Congress Presentation
Surgical history and arrhythmic outcomes in adults with congenital heart disease and implantable cardioverter-defibrillators
thumbnail
Congress Presentation
Implantable Cardioverter-Defibrillator therapy in adult congenital heart disease: insights from long-term follow-up at a tertiary center

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources